Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Document Period End Date	Mar. 28, 2020
Operating Activities:
Net income (loss)	$ (7.8)	$ 36.9
Depreciation and amortization	11.7	14.1
Foreign Currency Transaction Gain (Loss), Unrealized	(0.1)	0.0
Equity compensation	2.2	1.9
Amortization of deferred debt costs	0.4	0.2
Gain (Loss) on Disposition of Other Assets	0.0	(0.8)
Provision for bad debts	7.0	5.0
Write-down of inventories	2.9	2.7
Increase (Decrease) in Deferred Income Taxes	14.3	4.5
Accounts and notes receivable	6.5	25.0
Inventories	10.5	11.5
Non-trade amounts receivable	3.2	11.5
Prepaid expenses	1.2	0.5
Other assets	1.2	0.1
Accounts payable and accrued liabilities	(19.2)	(32.5)
Income taxes payable	(0.3)	(14.5)
Other liabilities	(4.9)	(2.5)
Net cash impact from hedging activity	1.9	(0.8)
Other	0.3	(0.1)
Net cash used in operating activities	(47.0)	(40.1)
Investing Activities:
Capital expenditures	(8.2)	(12.9)
Proceeds from disposal of property, plant and equipment	0.5	0.6
Net cash used in investing activities	(7.7)	(12.3)
Financing Activities:
Dividend payments to shareholders	0.0	(33.9)
Repurchase of common stock	0.0	(0.7)
Repayment of finance lease obligations	(0.3)	(0.3)
Net increase in short-term debt	121.0	84.1
Payments of Debt Issuance Costs	1.7	1.3
Net cash provided by financing activities	119.0	47.9
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(12.4)	3.1
Net change in cash, cash equivalents and restricted cash	51.9	(1.4)
Cash, cash equivalents and restricted cash at beginning of year	126.1	151.9
Cash, cash equivalents and restricted cash at end of period	$ 178.0	$ 150.5